PeerJ

Gene patterns linked to lung adenocarcinoma outcomes and tumor environment

Updated

Abstract

A three-gene signature (ADAM12, BTK, ERG) was identified that may predict outcomes in lung adenocarcinoma patients.

  • Ninety-three -related genes were identified, with 23 showing prognostic effects based on univariate analysis.
  • The hazard ratios for the prognostic genes ranged from 0.65 to 1.25, indicating varying levels of risk.
  • Seven genes were selected using LASSO regression, leading to the construction of the three-gene signature.
  • The three-gene signature effectively stratified patients into high-risk and low-risk groups in both training and testing datasets.
  • The area under the curve (AUC) for 3-year survival predictions in the GEO datasets was 0.718, 0.646, and 0.643 for different sets.
  • Immune analysis suggested that the low-risk group exhibited higher immune activity and expression of HLA genes compared to the high-risk group.

Simplified

Key numbers

0.718
Prognostic Gene Signature AUC
3-year area under curve (AUC) for the three GEO datasets.
93
Identified -related
Total identified related to the .
23
Prognostic
Number of showing prognostic effects.

Full Text

What this is

  • Lung adenocarcinoma (LADC) is the most common subtype of lung cancer, with a poor prognosis.
  • This research identifies a three-gene signature related to the () that predicts patient outcomes.
  • The study utilizes data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) to analyze gene expression profiles.

Essence

  • A three-gene signature (ADAM12, BTK, ERG) associated with the effectively predicts survival outcomes in lung adenocarcinoma patients.

Key takeaways

  • Ninety-three () related to the were identified, with 23 showing prognostic significance.
  • The three-gene signature stratified patients into high-risk and low-risk groups, demonstrating robust predictive power with a 3-year AUC of 0.718 in independent datasets.
  • Low-risk patients exhibited higher immune activity and expression of HLA genes compared to high-risk patients, suggesting a link between immune status and prognosis.

Caveats

  • The study relies on data from existing databases, which may introduce biases related to sample selection and data quality.
  • Further validation in larger, diverse cohorts is necessary to confirm the clinical utility of the three-gene signature.

Definitions

  • tumor microenvironment (TME): A complex network of tumor cells, immune cells, and stromal cells that influences tumor behavior and patient outcomes.
  • differentially expressed genes (DEGs): Genes that show statistically significant differences in expression levels between tumor and normal samples.

Simplified

Funding

Competing interests

The authors declare that they have no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free